A case of tuberculous peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD) in a 37-year-old man who presented with fever, abdominal pain, and a malfunctioning Tenckhoff catheter is reported. The patient was initially treated for presumed bacterial peritonitis but remained febrile and had persistent abdominal pain and peritoneal fluid pleocytosis, despite broad-spectrum antibiotic therapy. Mycobacterium tuberculosis was isolated in a culture of peritoneal fluid, and the patient responded promptly to antituberculous therapy. More than 50 cases of tuberculous peritonitis complicating CAPD that have been reported in the English-language literature since the initial case was reported in 1980 are reviewed. The most common symptoms are fever (78%), abdominal pain (92%), and cloudy dialysate (90%); 76% of cases had a predominance of polymorphonuclear cells in peritoneal fluid. A smear for acid-fast bacilli or a culture was positive in 73% of cases. The peritoneal dialysis catheter was removed in 53% of cases, although this was rarely considered necessary for cure of tuberculosis. The attributable mortality rate is 15%, with the most significant factor being treatment delay (mean time from presentation to initiation of treatment, 6.74 weeks). We conclude that tuberculosis is an important diagnostic consideration for CAPD patients with peritonitis that is refractory to broad-spectrum antibiotics.
Case Report
A 37-year-old man with a medical history of ESRD secondary to type 1 diabetes mellitus presented on 3 January 1998 because of a malfunctioning Tenckhoff catheter, subjective fever, abdominal pain, and fatigue, all of 1 week's duration. The presumptive diagnosis at the time of admission was bacterial peritonitis (his first such episode), and empirical therapy with cefazolin and gentamicin was initiated.
He had been dialysis-dependent for 1 year and had been undergoing CAPD for 6 months. Before admission, he denied chills, night sweats, cough, or weight loss. He denied prior exposure to tuberculosis and was uncertain about his PPD status. Upon admission, he had a temperature of 39.2ЊC; other vital signs were unremarkable. Physical examination findings were notable for diffuse abdominal tenderness, no peritoneal signs, and no erythema or exudate around the peritoneal dialysis catheter site. The initial sample of peritoneal dialysis fluid was cloudy, with 250 cells/mm 3 (73% polymorphonuclear cells [PMN] , 25% lymphocytes, and 2% eosinophils). The complete blood cell count at the time of admission was notable for a WBC count of 12,800 cells/ mm 3 , with a left shift. A chest radiograph at that time revealed no infiltrates, cavities, or calcifications.
Over the next 3 weeks, despite several courses of both intraperitoneal and systemic broad-spectrum antibiotics, the patient continued to have abdominal pain, fevers, and cloudy, culturenegative peritoneal fluid samples, usually PMN-predominant. A CT scan of the abdomen, gallium scan, and lumbar puncture were all nondiagnostic. His PPD was nonreactive. The Tenckhoff catheter was removed after hospital day 35, after isolation of Candida tropicalis from the peritoneal dialysis fluid. A smear for acid-fast bacilli obtained on hospital day 20 became positive on hospital day 37, and the organism was later identified as M. tuberculosis, a finding that prompted treatment with isoniazid, rifampin, ethambutol, and pyrazinamide. The patient responded promptly to the antituberculous therapy, with remission of fever and resolution of abdominal pain. He successfully completed a 9-month course of antituberculous therapy and is still undergoing hemodialysis.
Review of Case Reports
Methods. A computerized MEDLINE review of the English-language literature from January 1976 through January 1999 identified 51 reports of cases of peritoneal tuberculosis in patients undergoing CAPD. Cases were defined by either positive culture or histology suggestive of tuberculosis.
Results. Summaries of the 52 cases are provided in tables 1 and 2. Only 13 (25%) of the 52 cases were reported in the United States. Fifty-four percent of the patients were of Asian origin. The average age was 51 years, and 54% of cases occurred in women. Several of the laboratory and clinical characteristics are analyzed in table 3. In 27 cases (53%), the peritoneal dialysis catheter was removed before completion of therapy, usually because the peritonitis was not resolving, despite empirical antibacterial therapy. Less common reasons for catheter removal included catheter blockade, development of peritoneal signs, and ineffective dialysis. Still, in 28 cases (57%), CAPD was continued after the episode, and there was no significant difference in the treatment delay for those who underwent hemodialysis and those who continued with CAPD. Mortality was 25% at 9 months after diagnosis, and 8 of the 13 fatalities were related to peritoneal tuberculosis. The only statistically significant variable predicting death due to tuberculosis was treatment delay (table 4) . On average, treatment was initiated 4 weeks later for patients who eventually died of tuberculosis than it was for patients who survived or died of other causes (10.1 weeks vs. 6.2 weeks;
, Mann-Whit-P p .045 ney U test). The treatment regimens of the cases vary, since they span almost 20 years. However, the majority of cases were treated for 6-12 months.
Discussion
Tuberculosis remains a serious global health concern, since 13 million deaths annually worldwide are attributable to M. tuberculosis [31] . The pathogenesis of peritoneal tuberculosis in patients undergoing CAPD remains speculative. Patients with ESRD have relative deficits in the cell-mediated immunity required to prevent active tuberculosis [32] [33] [34] , and the RR for developing active tuberculosis in the ESRD population is at least 5-15 times higher than in the general population [35] [36] [37] [38] [39] [40] . There is also a higher rate of extrapulmonary tuberculosis in the ESRD population. Diabetes, which can lead to the need for CAPD, is also a known risk factor for tuberculosis. Defects in the local (i.e., peritoneal cavity) immunity unique to CAPD may predispose to active tuberculosis in the appropriate setting.
The immune mechanisms of the peritoneal cavity have not been clearly characterized. However, some in vitro studies suggest that the alterations in pH, osmolality, and peritoneal fluid volume that accompany peritoneal dialysis may hinder both phagocytic and lymphocytic activity in peritoneal fluid and thus allow for infection by a smaller inoculum of microorganisms [41] [42] [43] . Findings at laparotomy in several of the reviewed cases suggest reactivation of latent abdominal tuberculosis. Contiguous spread from the genitourinary tract could also cause peritoneal disease.
These cases demonstrate the difficulty in establishing the diagnosis, since it took an average of almost 7 weeks to initiate appropriate treatment. The presentation of abdominal pain, fever, and cloudy, PMN-predominant dialysate in patients who are undergoing CAPD can be caused by infection with either mycobacteria or other, more common pathogens. More than 75% of reported cases were in patients with no known risk factors for development of active tuberculosis. Seventy-eight percent of the cases reviewed had PMN-predominant pleocytosis on examination of the peritoneal fluid, and only 48% of the tuberculin skin tests (when done or reported) were positive. This contrasts with peritoneal tuberculosis not specifically related to CAPD, which is usually associated with lymphocytepredominant peritoneal fluid and a positive tuberculin skin test rate of 70%-100% [44] [45] [46] . Although 73% of cases were diagnosed by a positive smear or culture, there was a significant delay from presentation to submission of cultures for acid-fast bacilli in many instances (including our case). Tuberculous peritonitis should be considered in all cases of presumed bacterial peritonitis in which symptoms persist despite conventional antibacterial therapy.
Of the 51 case reports, 27 (53%) described removal of the peritoneal dialysis catheter before the completion of therapy. However, there are clearly cases that did not require interruption of CAPD, since effective peritoneal clearance and ultrafiltration were demonstrated during antituberculous therapy. Removal of the peritoneal dialysis catheter may not always be required, as long as symptoms abate and adequate dialysis continues.
The short-term (attributable) mortality associated with peritoneal tuberculosis in patients undergoing CAPD was 15%. Among 6 of the 8 cases in which death was caused by peritoneal tuberculosis, treatment was delayed for 16 weeks. The observed mortality rate of 15% is greater than the ∼7% seen with tuberculous peritonitis without CAPD [44, 46] . In the present review, of the 11 cases diagnosed by laparotomy, 6 had a treatment delay of р2 weeks (average, 3.5 weeks; all-case average, 6.7 weeks), with only 1 related death. Therefore, perhaps peritoneal biopsy may play a role in reducing the treatment delay seen with this entity.
In all cases for which such data were reported, treatment involved the administration of 2-4 antituberculous agents for at least 6 months. As with other cases of extrapulmonary tuberculosis [47, 48] , 9 months of therapy should suffice with a regimen based on susceptibility findings. It is beyond the scope of this review to provide recommendations on treatment of tuberculosis in cases of renal failure, but we refer readers to reviews of this subject [49, 50] .
In summary, a high index of suspicion must always be maintained for CAPD-associated tuberculous peritonitis because of its relative rarity, because Mantoux tuberculin skin tests are frequently negative, extra-abdominal disease is lacking, and its presentation is similar to and/or accompanied by infections with nonmycobacterial pathogens.
